Skip to main content

and
  1. Article

    Open Access

    Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition

    The moderate glucose-lowering effect of sodium glucose co-transporter 2 (SGLT2) inhibitors is unlikely to explain SGLT2 inhibitor-mediated beneficial outcomes, and unravelling the underlying mechanisms is a hi...

    Lakshini Y. Herat, Jennifer Matthews, Omar Azzam in Current Hypertension Reports (2022)

  2. No Access

    Article

    New Molecules for Treating Resistant Hypertension: a Clinical Perspective

    To review the findings of trials evaluating pharmacological treatment approaches for hypertension in general, and resistant hypertension (RH) in particular, and propose future research and clinical directions.

    Omar Azzam, Marcio G. Kiuchi, Jan K. Ho, Vance B. Matthews in Current Hypertension Reports (2019)